Opus Genetics, INC. (IRD) SEC Filings — 2024
11 SEC filings for Opus Genetics, INC. (IRD) in 2024.
Filings
- Opus Genetics Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
- Foundation Fighting Blindness Files 13D on Opus Genetics — SC 13D · Oct 29, 2024
- Ocuphire Pharma Acquired by Lumina Acquisition Corp. — 8-K · Oct 22, 2024
- Ocuphire Pharma Files Q2 2024 10-Q — 10-Q · Aug 13, 2024
- Ocuphire Pharma Files 8-K with Corporate Updates — 8-K · Jun 13, 2024
- Ocuphire Pharma Files 8-K on Operations and Financials — 8-K · May 10, 2024
- Ocuphire Pharma Schedules 2024 Annual Meeting of Stockholders for June 11 — DEF 14A · Apr 29, 2024
- Ocuphire Pharma Appoints New Director — 8-K · Apr 17, 2024
- Ocuphire Pharma Files 8-K for Disclosure and Exhibits — 8-K · Mar 27, 2024
- Ocuphire Pharma Files 2023 Annual Report on Form 10-K — 10-K · Mar 8, 2024
- Ocuphire Pharma Reports Officer Compensation Changes — 8-K · Feb 16, 2024